A recently developed cognitive-behavioral treatment for generalized anxiety disorder (GAD) targets intolerance of uncertainty by the reevaluation of positive beliefs about worry, problem-solving training, and cognitive exposure. As previous studies have established the treatment's efficacy when delivered individually, the present study tests the treatment in a group format as a way to enhance its cost-benefit ratio. A total of 52 GAD patients received 14 sessions of cognitive-behavioral therapy in small groups of 4 to 6 participants. A wait-list control design was used, and standardized clinician ratings and self-report questionnaires assessed GAD symptoms, intolerance of uncertainty, anxiety, depression, and social adjustment. Results show that the treatment group, relative to the wait-list group, had greater posttest improvement on all dependent variables and that treated participants made further gains over the 2-year follow-up phase of the study.

Schema theory was developed for patients with chronic psychological problems who fail to make significant gains in cognitive therapy. Although the theory has been applied most frequently to personality disorders, mood and anxiety disorders may also be a relevant application. This article reviews the literature applying schema theory to mood and anxiety disorders. The literature suggests that people with mood and anxiety disorders present high levels of early maladaptive schemas, some of which would appear to reflect the characteristics of the individual disorders. Preliminary research suggests that schema therapy may be successfully extended to mood and anxiety disorders. Further research is necessary to examine the utility of schema therapy for these clienteles and to identify the individuals who stand to benefit most.

This study aims to validate the French-Canadian adaptation of the third version of the Young Schema Questionnaire (YSQ-S3;Young, 2005) and provide expected scores for nonclinical and Axis I patient samples. The Young Schema Questionnaire assesses early maladaptive schemas (EMSs) and schema domains. The latest version of the questionnaire, the YSQ-S3, has received little attention, and its Canadian French adaptation has yet to be validated. In this study, a sample of 973 nonclinical participants completed the YSQ-S3, as well as assessments of their self-reported clinical or nonclinical status. A mixed Axis I patient group of 96 participants also completed the YSQ-S3 and additional clinical measures. Confirmatory factor analysis supports the EMSs but fails to support the schema domains. Expected scores for Axis I patients and confirmed nonclinical respondents are presented. As a whole, the French-Canadian version of the YSQ-S3 is a solid tool for the self-report measurement of EMSs. However, caution should be used in using and interpreting domain scores.

No abstract

Mood and anxiety disorders are the most prevalent mental disorders. People with such disorders implement self-management strategies to reduce or prevent their symptoms and to optimize their health and well-being. Even though self-management strategies are known to be essential to recovery, few researchers have examined them. The aim of this study is to explore strategies used by people recovering from depressive, anxiety, and bipolar disorders by asking 50 of them to describe their own strategies. Strategies were classified according to dimensions of recovery: social, existential, functional, physical, and clinical. Within these themes, 60 distinct strategies were found to be used synergistically to promote personal recovery as well as symptom reduction. Findings highlight the diversity of strategies used by people, whether they have depressive, anxiety, or bipolar disorders. This study underscores the importance of supporting self-management in a way that respects individual experience.